Age related mitochondrial degenerative disorders in humans

Biotechnology Journal

Volumn 3, Issue 6, 2008, Pages 750-756

  Reeve, Amy K ^a   Krishnan, Kim J ^a   Turnbull, Doug M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Ageing; Mitochondria; Neurodegeneration

Indexed keywords

AGE-RELATED; ALZHEIMER'S DISEASE (AD); BRAIN REGIONS; CELL LOSS; MITOCHONDRIAL DNA (MTDNA); MITOCHONDRIAL FUNCTIONS; MITOCHONDRIAL GENOMES; MITOCHONDRIAL RESPIRATORY CHAIN; NEURO-DEGENERATIVE DISEASE; NEURODEGENERATIVE CONDITIONS; PARKINSON'S DISEASE (PD);

DNA; ELECTRIC MACHINE INSULATION; GENES; HEALTH; NUCLEIC ACIDS; ORGANIC ACIDS;

MITOCHONDRIA;

DJ 1 PROTEIN; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN;

AGING; ALZHEIMER DISEASE; BRAIN REGION; CELL LOSS; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE MUTATION; HAPLOTYPE; HUMAN; MITOCHONDRIAL GENE; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; NEUROLOGIC DISEASE; OXIDATIVE STRESS; PARKINSON DISEASE; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RESPIRATORY CHAIN; REVIEW; BRAIN; METABOLISM; MITOCHONDRION;

AGING; BRAIN; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MITOCHONDRIAL PROTEINS; NEURODEGENERATIVE DISEASES;

EID: 48949119268     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.200800066     Document Type: Review

References (61)

1. Hengartner, M. O., The biochemistry of apoptosis. Nature 2000, 407, 770-776.
2. Rizzuto, R., Bernardi, P., Pozzan, T., Mitochondria as all-round players of the calcium game. J. Physiol. 2000, 529, 37-47.
3. Chen, H., Chan, D. C., Emerging functions of mammalian mitochondrial fusion and fission. Hum. Mol. Genet. 2005, 14, R283-289.
4. Margulis, L., Symbiosis and evolution. Sci. Am. 1971, 225, 48-57.
5. Frey, T. G., Renken, C. W, Perkins, G. A., Insight into mitochondrial structure and function from electron tomography. Biochim. Biophys. Acta 2002, 1555, 196-203.
6. Harman, D., Ageing: A theory based on free radical and radiation chemistry. J. Gerontol. 1956, 2, 298-300.
7. Linnane, A. W., Marzuki, S., Ozawa, T., Tanaka, M., Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989, 1, 642-645.
8. Schaefer, A. M., Phoenix, C., Elson, J. L., McFarland, R. et al., Mitochondrial disease in adults: A scale to monitor progression and treatment. Neurology 2006, 66, 1932-1934.
9. Taylor, R. W., Turnbull, D. M., Mitochondrial DNA mutations in human disease. Nat. Rev. 2005, 6, 389-402.
10. Brierley, E. J., Johnson, M. A., Lightowlers, R. N., James, O. F., Turnbull, D. M., Role of mitochondrial DNA mutations in human aging: Implications for the central nervous system and muscle. Ann. Neurol. 1998, 43, 217-223.
11. McFarland, R., Taylor, R. W., Turnbull, D. M., Mitochondrial disease - Its impact, etiology and pathology. Curr. Top. Dev. Biol. 2007, 77, 113-155.
12. Betts, J., Jaros, E., Perry, R. H., Schaefer, A. M. et al., Molecular neuropathology of MELAS: Level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol. Appl. Neurobiol. 2006, 32, 359-373.
13. Betts, J., Lightowlers, R. N., Turnbull, D. M., Neuropathological aspects of mitochondrial DNA disease. Neurochem. Res. 2004, 29, 505-511.
14. Filosto, M., Tomelleri, G., Tonin, P., Scarpelli, M. et al., Neuropathology of mitochondrial diseases. Biosci. Rep. 2007, 27, 23-30.
15. Aure, K., Fayet, G., Leroy J. P., Lacene, E. et al., Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation. Brain 2006, 129, 1249-1259.
16. Penny, D., Steel, M., Waddell, P. J., Hendy, M. D., Improved analyses of human mtDNA sequences support a recent African origin for Homo sapiens. Mol. Biol. Evol. 1995, 12, 863-882.
17. Horai, S., Hayasaka, K., Kondo, R., Tsugane, K., Takahata, N., Recent African origin of modern humans revealed by complete sequences of hominoid mitochondrial DNAs. Proc. Natl. Acad. Sci. USA 1995, 92, 532-536.
18. Ghezzi, D., Marelli, C., Achilli, A., Goldwurm, S. et al., Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur. J. Hum. Genet. 2005, 13, 748-752.
19. Autere, J., Moilanen, J. S., Finnila, S., Soininen, H. et al., Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia. Hum. Genet. 2004, 115, 29-35.
20. Ross, O. A., McCormack, R., Maxwell, L. D., Duguid, R. A. et al., mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish. Exp. Gerontol. 2003, 38, 397-405.
21. Pyle, A., Foltynie, T., Tiangyou, W., Lambert, C. et al., Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann. Neurol. 2005, 57, 564-567.
22. van der Walt, J. M., Nicodemus, K. K., Martin, E. R., Scott, W. K. et al., Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet. 2003, 72, 804-811.
23. Carrieri, G., Bonafe, M., De Luca, M., Rose, G. et al., Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Hum. Genet. 2001, 108, 194-198.
24. Chagnon, P., Gee, M., Filion, M., Robitaille, Y. et al., Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. Am. J. Med. Genet. 1999, 85, 20-30.
25. Chinnery, P. F., Taylor, G. A., Howell, N., Andrews, R. M. et al., Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology 2000, 55, 302-304.
26. Elson, J. L., Herrnstadt, C., Preston, G., Thal, L. et al., Does the mitochondrial genome play a role in the etiology of Alzheimer's disease? Hum. Genet. 2006, 119, 241-254.
27. van der Walt, J. M., Dementieva, Y. A., Martin, E. R., Scott, W. K. et al., Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci. Lett. 2004, 365, 28-32.
28. Malka, F., Lombes, A., Rojo, M., Organization, dynamics and transmission of mitochondrial DNA: Focus on vertebrate nucleoids. Biochim. Biophys. Acta 2006, 1763, 463-472.
29. Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A. et al., High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 2006, 38, 515-517.
30. Cottrell, D. A., Blakely, E. L., Johnson, M. A., Ince, P. G., Turnbull, D. M., Mitochondriai enzyme-deficient hippocampal neurons and choroidal cells in AD. Neurology 2001, 57, 260-264.
31. Kraytsberg, Y., Kudryavtseva, E., McKee, A. C., Geula, C. et al., Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat. Genet. 2006, 38, 518-520.
32. Reeve, A. K., Krishnan, K. J., Elson, J. L, Morris, C. M. et al., Nature of mitochondrial DNA deletions in substantia nigra neurons. Am. J. Hum. Genet. 2008, 82, 228-235.
33. Krishnan, K. J., Reeve, A. K., Samuels, D. C., Chinnery, P. F. et al., What causes mitochondrial DNA deletions in human cells? Nat. Genet. 2008, 40, 275-279.
34. Gai, W. P., Yuan, H. X., Li, X. Q., Power, J. T. et al., In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp. Neurol. 2000, 166, 324-333.
35. Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H. et al., Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 2006, 441, 1162-1166.
36. Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S. et al., Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 2004, 279, 18614-18622.
37. Andres-Mateos, E., Perier, C., Zhang, L., Blanchard-Fillion, B. et al., DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc. Natl. Acad. Sci. USA 2007, 104, 14807-14812.
38. Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. et al., Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004, 304, 1158-1160.
39. Valente, E. M., Salvi, S., Ialongo, T., Marongiu, R. et al., PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann. Neurol. 2004, 56, 336-341.
40. Hatano, Y., Li, Y., Sato, K., Asakawa, S. et al., Novel PINK1 mutations in early-onset parkinsonism. Ann. Neurol. 2004, 56, 424-427.
41. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y. et al., Familial Parkinson disease gene product, parkin. is a ubiquitin-protein ligase. Nat. Genet. 2000, 25, 302-305.
42. Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C. et al., Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 2003, 278, 43628-43635.
43. Darios, F., Corti, O., Lucking, C. B., Hampe, C. et al., Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum. Mol. Genet. 2003, 12, 517-526.
44. Hague, S., Rogaeva, E., Hernandez, D., Gulick, C. et al., Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. Ann. Neurol. 2003, 54, 271-274.
45. Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O. et al., Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299, 256-259.
46. Payami, H., Zareparsi, S., James, D., Nutt, J., Familial aggregation of Parkinson disease: A comparative study of early-onset and late-onset disease. Arch. Neurol. 2002, 59, 848-850.
47. Shendelman, S., Jonason, A., Martinat, C., Leete, T, Abeliovich, A., DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol. 2004, 2, e362.
48. Canet-Aviles, R. M., Wilson, M. A., Miller, D. W., Ahmad, R. et al., The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. USA 2004, 101, 9103-9108.
49. Taira, T., Saito, Y., Niki, T., Iguchi-Ariga, S. M. et al., DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 2004, 5, 213-218.
50. Ropp, P. A., Copeland, W. C., Cloning and characterization of the human mitochondrial DNA polymerase, DNA polymerase gamma. Genomics 1996, 36, 449-458.
51. Luoma, P., Melberg, A., Rinne, J. O., Kaukonen, J. A. et al., Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: Clinical and molecular genetic study. Lancet 2004, 364, 875-882.
52. Luoma, P. T., Eerola, J., Ahola, S., Hakonen, A. H. et al., Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease. Neurology 2007, 69, 1152-1159.
53. Tiangyou, W., Hudson, G., Ghezzi, D., Ferrari, G. et al., POLG1 in idiopathic Parkinson disease. Neurology 2006, 67, 1698-1700.
54. Ekstrand, M. I., Terzioglu, M., Galter, D., Zhu, S. et al., Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc. Natl. Acad. Sci. USA 2007, 104, 1325-1330.
55. Gu, M., Owen, A. D., Toffa, S. E., Cooper, J. M. et al., Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. J. Neurol. Sci. 1998, 158, 24-29.
56. Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., Anandatheerthavarada, H. K., Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci. 2006, 26, 9057-9068.
57. Manczak, M., Anekonda, T. S., Henson, E., Park, B. S. et al., Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: Implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 2006, 15, 1437-1449.
58. Castellani, R., Hirai, K., Aliev, G., Drew, K. L. et al., Role of mitochondrial dysfunction in Alzheimer's disease. J. Neurosci. Res. 2002, 70, 357-360.
59. Aliev, G., Seyidova, D., Neal, M. L., Shi, J. et al., Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann. N. Y. Acad. Sci. 2002, 977, 45-64.
60. Perry, G., Cash, A. D., Smith, M. A., Alzheimer disease and oxidative stress. J. Biomed. Biotechnol. 2002, 2, 120-123.
61. Aliev, G., Obrenovich, M. E., Smith, M. A., Perry, G., Hypoperfusion, mitochondria failure, oxidative stress, and Alzheimer disease. J. Biomed. Biotechnol. 2003, 2003, 162-163.